Home › Trials › NCT03547856
Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Registry on controlling blood pressure in ten thousand patients

Official title: A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"

Run by Shanghai Institute of Hypertension · NCT03547856 · Data updated 2026-11-12

This study is testing how well 24-hour blood pressure monitoring can help people with high blood pressure manage their condition and improve their heart health.

More Hypertension trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment10000 (estimated)
SponsorShanghai Institute of Hypertension
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedJuly 18, 2018
Main results expectedSeptember 30, 2026
Study endsDecember 30, 2026
Registry record updatedJanuary 6, 2025
Trial IDNCT03547856 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18-80 with clinically diagnosed hypertension who are currently using antihypertensive medications.

Probably not a fit

Patients who are not on antihypertensive drugs or those who are hospitalized for hypertension may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to register information on hypertensive patients using 24-hour ambulatory blood pressure (ABP) monitoring across China. It seeks to evaluate the effectiveness of ABP monitoring in managing hypertension and its impact on cardiovascular outcomes. The study highlights the importance of accurate blood pressure measurement in daily life to identify various forms of hypertension that traditional methods may miss. By promoting the clinical application of ABP monitoring, the study aims to improve hypertension management and reduce associated health risks.

Why it matters

Potential benefit: If successful, this study could lead to improved management of hypertension and a reduction in cardiovascular events among patients.

How similar studies have gone: Previous studies have shown success with ambulatory blood pressure monitoring, indicating its potential effectiveness in managing hypertension.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Age 18-80 years old
* Clinical diagnosed hypertension with the use of antihypertensive drugs
* A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.
* Willing to provide information about disease history and blood biochemical test data within 6 months.
* Sign the informed consent

Exclusion Criteria:

* Without antihypertensive drug use
* Hospitalized hypertension patients
* Non-compliant patient

Where it's running

  • Ruijin Hospital
    Shanghai, Shanghai Municipality, China     Recruiting

Study contacts

  • Principal investigator: Yan Li — Shanghai Institute of Hypertension
  • Study coordinator: Yan Li, Professor
  • Email: liyanshcn@yahoo.com
  • Phone: 021-64370045

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Hypertension 1034Blood Pressure 324Cardiovascular Diseases 365Shanghai Institute of Hypertension 4
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.